Polygenic Liability, Stressful Life Events and Risk for Secondary-treated Depression in Early Life: a Nationwide Register-based Case-cohort Study
Overview
Authors
Affiliations
Background: In this study, we examined the relationship between polygenic liability for depression and number of stressful life events (SLEs) as risk factors for early-onset depression treated in inpatient, outpatient or emergency room settings at psychiatric hospitals in Denmark.
Methods: Data were drawn from the iPSYCH2012 case-cohort sample, a population-based sample of individuals born in Denmark between 1981 and 2005. The sample included 18 532 individuals who were diagnosed with depression by a psychiatrist by age 31 years, and a comparison group of 20 184 individuals. Information on SLEs was obtained from nationwide registers and operationalized as a time-varying count variable. Hazard ratios and cumulative incidence rates were estimated using Cox regressions.
Results: Risk for depression increased by 35% with each standard deviation increase in polygenic liability ( < 0.0001), and 36% ( < 0.0001) with each additional SLE. There was a small interaction between polygenic liability and SLEs ( = -0.04, = 0.0009). The probability of being diagnosed with depression in a hospital-based setting between ages 15 and 31 years ranged from 1.5% among males in the lowest quartile of polygenic liability with 0 events by age 15, to 18.8% among females in the highest quartile of polygenic liability with 4+ events by age 15.
Conclusions: These findings suggest that although there is minimal interaction between polygenic liability and SLEs as risk factors for hospital-treated depression, combining information on these two important risk factors could potentially be useful for identifying high-risk individuals.
Guare L, Das J, Caruth L, Setia-Verma S Pac Symp Biocomput. 2024; 30:296-313.
PMID: 39670378 PMC: 11658798.
Shi R, Li Y, Zhu W, Xin H, Yang H, Feng X Int J Mol Sci. 2024; 25(15).
PMID: 39125645 PMC: 11311262. DOI: 10.3390/ijms25158075.
Schowe A, Godara M, Czamara D, Adli M, Singer T, Binder E Eur Arch Psychiatry Clin Neurosci. 2024; 275(1):61-73.
PMID: 38587666 PMC: 11799032. DOI: 10.1007/s00406-024-01795-y.
Crouse J, Park S, Byrne E, Mitchell B, Scott J, Medland S Mol Psychiatry. 2024; 29(9):2765-2773.
PMID: 38575805 PMC: 11420070. DOI: 10.1038/s41380-024-02492-x.
Peter H, Giglberger M, Streit F, Frank J, Kreuzpointner L, Rietschel M Genes Brain Behav. 2023; 22(6):e12872.
PMID: 37876358 PMC: 10733580. DOI: 10.1111/gbb.12872.